-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
Co-Chair
-
University of California, San Diego, La Jolla, California
Co-Chair
-
Parkinson's Foundation, New York, New York
-
University of Rochester, Rochester, New York (2016-2019)
-
Helen Bronte-Stewart, MD, MS
Stanford University School of Medicine, Stanford, California
-
Coeruleus Clinical Sciences LLC, Woodbridge, Connecticut
-
Medical University of South Carolina, Charleston, South Carolina (2016-2019)
-
Columbia University Medical Center, New York, New York
-
Indiana University School of Medicine, Indianapolis, Indiana (2016-2019)
-
Rush University Medical Center, Chicago, Illinois
-
Columbia University Medical Center, New York, New York (2016-2019)
-
University of Florida, Gainesville, Florida
-
Oregon Health and Science University, Portland, Oregon (2016-2019)
-
Parkinson's Foundation, Falls Church, Virginia
-
Kathleen Shannon, MD, FAAN, FANA
University of Wisconsin, Madison, Wisconsin
-
Avid Radiopharmaceuticals, Inc., Philadelphia, Pennsylvania (2016-2019)
-
University of California, San Francisco, San Francisco, California (2016-2019)
-
University of Pennsylvania, Philadelphia, Pennsylvania (2016-2019)
-
Columbia University Medical Center, New York, New York
Chair
-
Newcastle University, Newcastle upon Tyne, United Kingdom
-
University of Louisville, Louisville, Kentucky
-
National Institute on Aging (NIA), National Institutes of Health (NIH), Bethesda, Maryland
-
National Institute on Aging (NIA), National Institutes of Health (NIH), Bethesda, Maryland Ad hoc member
-
Rush University Medical Center, Chicago, Illinois
-
Pacific Health Research Institute, Honolulu, Hawaii
Chair
-
Alberto Ascherio, MD, DrPh
Harvard School of Public Health, Boston, Massachusetts
-
University of Bristol, Bristol, United Kingdom
-
National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Bethesda, Maryland hoc member
-
University of Toronto, Toronto, Canada
-
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia
-
Emory University, Atlanta, Georgia
Chair
-
University of Hospital Kiel, Kiel, Germany
-
Stanford University School of Medicine, Palo Alto, California
-
University of Toronto, Toronto, Canada
-
University of Kansas Medical Center, Kansas City, Kansas
-
University of California, San Francisco, San Francisco, California
-
Cleveland Clinic, Cleveland, Ohio
-
Institute for Neurodegenerative Disorders, New Haven, Conneticut
Chair
-
Imperial College, London, United Kingdom
-
New York University School of Medicine, New York, New York
-
University of Alberta, Edmonton, Canada
-
Washington University, St Louis, Missouri
-
Medical University Innsbruck, Innsbruck, Austria
-
Medical University Innsbruck, Innsbruck, Austria
-
Medical University of South Carolina, Charleston, South Carolina
Chair
-
University of Alabama Birmingham, Birmingham, Alabama
-
Columbia University, New York, New York
-
Pablo Martinez-Martin, MD, PhD
National Center for Epidemiology, ISCIII, Madrid, Spain
-
University of Rochester, Rochester, New York
-
New York University, New York, New York
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
NINDS CDE Project Officer, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
-
The Emmes Corporation
-
The Emmes Corporation
-
The Emmes Corporation
-
The Emmes Corporation
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland
-
KAI Research, Inc. (An Altarum Company), Rockville, Maryland